Jennifer B. Dean

Dr. Jennifer B. Dean

Pediatric Hematology Oncology
Johns Hopkins Medicine
Johns Hopkins All Children's Outpatient Care, St. Petersburg
601 5th Street South, Suite 320, Suite 320, 
Saint Petersburg, FL 
Offers Telehealth

Johns Hopkins Medicine
Johns Hopkins All Children's Outpatient Care, St. Petersburg
601 5th Street South, Suite 320, Suite 320, 
Saint Petersburg, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dr. Dean is a hematologist-oncologist in the Johns Hopkins All Children’s Cancer & Blood Disorders Institute. She joined the hospital staff in 2021. She was previously an attending physician with Pediatric Specialists of Virginia in the Center for Cancer and Blood Disorders and with Children’s National Hospital. Dr. Dean was the director of the Long-Term Follow-Up program at Pediatric Specialists of Virginia and Children’s National Hospital and director of the neuro-oncology program at Pediatric Specialists of Virginia. She was also a senior physician on the leukemia and lymphoma team. She was an assistant professor in the Department of Pediatrics at George Washington University School of Medicine and Health Science. Dr. Dean has published peer-reviewed articles, authored book chapters and lectured both nationally and internationally. Her clinical and research interests include the impact of physical activity on overall function, cardiac function and quality of life in leukemia and lymphoma patients. Dr. Dean earned her medical degree from Wake Forest University in Winston-Salem, North Carolina. She completed an internship and residency in pediatrics and a fellowship in pediatric hematology-oncology at St. Louis Children’s Hospital/Washington University in St. Louis.

Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Immune Thrombocytopenic Purpura (ITP), and Neurofibromatosis Type 1 (NF1).

Her clinical research consists of co-authoring 4 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Residency
St. Louis Children's Hospital, Pediatrics, 2004
Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in VA
Board Certifications
American Board Of Pediatrics
Fellowships
St. Louis Children's Hospital, Pediatric Hematology-Oncology, 2007
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 9 Less Insurance Carriers -

Locations

Johns Hopkins All Children's Outpatient Care, St. Petersburg
601 5th Street South, Suite 320, Suite 320, Saint Petersburg, FL 33701
Call: 727-767-4176

Additional Areas of Focus

Dr. Dean has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)
Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2025
Intervention Type: Drug, Biological, Procedure, Other, Radiation
Study Drugs: Brentuximab, Dacarbazine, Doxorubicin, Filgrastim, Nivolumab, Pegfilgrastim, Vinblastine
Study Phase: Phase 3
A Phase I Study With an Expansion Cohort/Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients With Relapsed/Refractory Hodgkin Lymphoma
A Phase I Study With an Expansion Cohort/Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients With Relapsed/Refractory Hodgkin Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Procedure, Drug, Biological
Study Drugs: Brentuximab, Ipilimumab, Nivolumab
Study Phase: Phase 1/Phase 2
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Drug, Biological, Radiation
Study Drugs: Erwinia Asparaginase, Blinatumomab, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin Hydrochloride, Leucovorin Calcium, Mercaptopurine, Methotrexate, Pegaspargase, Prednisolone, Prednisone, Thioguanine, Vincristine Sulfate
Study Phase: Phase 3
View 2 Less Clinical Trials

4 Total Publications

Association between medical comorbidities at diagnosis and paediatric acute lymphoblastic leukaemia and lymphoblastic lymphoma outcomes: protocol for a systematic review.
Association between medical comorbidities at diagnosis and paediatric acute lymphoblastic leukaemia and lymphoblastic lymphoma outcomes: protocol for a systematic review.
Journal: BMJ open
Published: June 06, 2025
View All 4 Publications
Similar Doctors
Adrianna Vlachos
Expertise in
15
conditions
Dr. Adrianna Vlachos
Hematology | Pediatric Hematology Oncology
Expertise in
15
conditions
Dr. Adrianna Vlachos
Hematology | Pediatric Hematology Oncology

Johns Hopkins All Children's Outpatient Care, St. Petersburg

Saint Petersburg, FL 
 (828.7 miles away)
727-767-4176
Languages Spoken:
English, Greek
See accepted insurances
Offers Telehealth

Dr. Vlachos is the chief of hematology in the Johns Hopkins All Children’s Hospital Cancer & Blood Disorders Institute in St. Petersburg, Florida, and professor of pediatrics (PAR) in the Johns Hopkins University School of Medicine. She joined the hospital staff in 2024. She was previously professor of pediatrics at Zucker School of Medicine at Hofstra/Northwell and attending physician in hematology/oncology at Cohen Children’s Medical Center/Northwell Health, where she was head of the Bone Marrow Failure Program and head of the pediatric hematology/oncology trials office. Dr. Vlachos is internationally known for clinical care and expertise in bone marrow failure syndromes and her transformational research in Diamond Blackfan anemia (DBA) syndrome, a rare inherited bone marrow failure syndrome. Dr. Vlachos is the founder and has directed the Diamond Blackfan Anemia Registry (DBAR) of North America since its inception in 1991. She is the principal investigator and co-investigator on multiple grants funded by the National Institute of Health and the Centers for Disease Control and Prevention. She has published numerous articles on her research findings and has been invited to author papers and book chapters on bone marrow failure syndromes and DBA. Dr. Vlachos is a member of the Medical and Scientific Advisory Board for the Shwachman-Diamond Syndrome Registry, is a member of the Scientific Advisory Board for the Diamond Blackfan Anemia Foundation and holds a position on the Scientific Program Committee for Bone Marrow Failure of the American Society of Hematology. She earned her medical degree from New York Medical College in Valhalla, New York. She completed her residency in pediatrics at North Shore University Hospital in Manhasset, New York. She then completed a clinical fellowship in bone marrow transplantation at North Shore University Hospital, followed by a fellowship in pediatric hematology-oncology and bone marrow transplantation at Mount Sinai Medical Center in New York. Videos Bone Marrow Failure Syndrome Expert Dr. Adrianna Vlachos at Johns Hopkins All Children’s. Dr. Vlachos is highly rated in 15 conditions, according to our data. Her top areas of expertise are Aase Syndrome, Pure Red Cell Aplasia, Aplastic Anemia, and Transient Erythroblastopenia of Childhood.

Expertise in
9
conditions
Dr. Damon R. Reed
Pediatric Hematology Oncology
Expertise in
9
conditions
Dr. Damon R. Reed
Pediatric Hematology Oncology
12902 Usf Magnolia Dr, Fob1 Sarcoma Program, 
Tampa, FL 
 (805.2 miles away)
813-745-3242
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Damon Reed is a Pediatric Hematologist Oncology provider in Tampa, Florida. Dr. Reed is highly rated in 9 conditions, according to our data. His top areas of expertise are Osteosarcoma, Ewing Sarcoma, Adult Soft Tissue Sarcoma, and Rhabdomyosarcoma.

Expertise in
14
conditions
Dr. Don Eslin
Pediatric Hematology Oncology
Expertise in
14
conditions
Dr. Don Eslin
Pediatric Hematology Oncology
3001 W Dr Martin Luther King Jr Blvd Fl 1, 
Tampa, FL 
 (813.3 miles away)
813-321-6820
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Don Eslin is a Pediatric Hematologist Oncology provider in Tampa, Florida. Dr. Eslin is highly rated in 14 conditions, according to our data. His top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Neuroblastoma, Medulloblastoma, Glioma, and Bone Marrow Aspiration.

VIEW MORE Pediatric Hematologist Oncologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dean's expertise for a condition
ConditionClose
        • Experienced
        • Acute Lymphoblastic Leukemia (ALL)
          Dr. Dean is
          Experienced
          . Learn about Acute Lymphoblastic Leukemia (ALL).
          See more Acute Lymphoblastic Leukemia (ALL) experts
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile
        1. Homepage
        2. Pediatric Hematologist Oncologists Saint Petersburg, FL
        3. Dr. Jennifer B. Dean
        For Patients
        • Our Story
        • How MediFind Works
        • Conditions A-Z
        • Doctor Directory
        • Symptoms Directory
        • Procedures Directory
        • Treatment Directory
        • Drug Directory
        • Infusion Center Finder
        • FAQ
        • Contact Us
        For Providers and Practices
        • Claim Your Profile
        • Newsroom
        Business Solutions
        • Provider
        • Network Solutions
        Additional Resources
        • Consumer Health Data Privacy Policy
        • Privacy Policy
        • Terms of Use
        • Advertising Policy
        • Content Policy
        Subscribe to our newsletter

        Sign up to stay informed about MediFind and get wellness sent your way.

        Close

          By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

          Bullet PinMediFind
          Follow us on
          This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
          © 2026 All Rights Reserved

          Request an Appointment

          If you are experiencing a medical emergency, call 9-1-1.

          MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

            Close
            0 / 1000

            Please provide us with the below insurance information:

                    By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.